Literature DB >> 9928994

Inhibition of platelet aggregation by S-nitroso-cysteine via cGMP-independent mechanisms: evidence of inhibition of thromboxane A2 synthesis in human blood platelets.

D Tsikas1, M Ikic, K S Tewes, M Raida, J C Frölich.   

Abstract

S-Nitroso-cysteine (SNC), a putative endothelium-derived relaxing factor, potently inhibited collagen- and arachidonic acid-induced platelet aggregation (IC50=100 nM) and thromboxane A2 (TxA2) synthesis of human blood platelets. ODQ, a selective inhibitor of the soluble guanylyl cyclase, inhibited SNC-induced formation of cGMP but did not reverse inhibition by SNC of collagen- and arachidonic acid-induced platelet aggregation. Combination of ODQ with SQ-29548, a specific platelet TxA2 receptor antagonist, did not modify the antiaggregatory action of SNC. Our study shows that SNC inhibits platelet aggregation by cGMP-independent mechanisms that may involve inhibition of TxA2 synthesis in human platelets.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9928994     DOI: 10.1016/s0014-5793(98)01633-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  15 in total

Review 1.  S-nitrosothiols as selective antithrombotic agents - possible mechanisms.

Authors:  M P Gordge; F Xiao
Journal:  Br J Pharmacol       Date:  2010-03-08       Impact factor: 8.739

Review 2.  S-nitrosylation in cardiovascular signaling.

Authors:  Brian Lima; Michael T Forrester; Douglas T Hess; Jonathan S Stamler
Journal:  Circ Res       Date:  2010-03-05       Impact factor: 17.367

3.  Administration of glutathione in patients with type 2 diabetes mellitus increases the platelet constitutive nitric oxide synthase activity and reduces PAI-1.

Authors:  V Martina; G A Bruno; E Zumpano; C Origlia; L Quaranta; G P Pescarmona
Journal:  J Endocrinol Invest       Date:  2001-01       Impact factor: 4.256

4.  Regulation of platelet granule exocytosis by S-nitrosylation.

Authors:  Craig N Morrell; Kenji Matsushita; Kelly Chiles; Robert B Scharpf; Munekazu Yamakuchi; Rebecca J A Mason; Wolfgang Bergmeier; Joseph L Mankowski; William M Baldwin; Nauder Faraday; Charles J Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-28       Impact factor: 11.205

5.  A potential role for extracellular nitric oxide generation in cGMP-independent inhibition of human platelet aggregation: biochemical and pharmacological considerations.

Authors:  Michael S Crane; Adriano G Rossi; Ian L Megson
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

Review 6.  Nitric oxide regulation of protein trafficking in the cardiovascular system.

Authors:  Charles J Lowenstein
Journal:  Cardiovasc Res       Date:  2007-04-03       Impact factor: 10.787

7.  Cyclic GMP-independent mechanisms contribute to the inhibition of platelet adhesion by nitric oxide donor: a role for alpha-actinin nitration.

Authors:  Sisi Marcondes; Marcia H M Cardoso; Rafael P Morganti; Sara M Thomazzi; Sergio Lilla; Ferid Murad; Gilberto De Nucci; Edson Antunes
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

8.  Platelet aggregation is affected by nitrosothiols in patients with chronic hepatitis: in vivo and in vitro studies.

Authors:  A Federico; A Filippelli; M Falciani; C Tuccillo; A Tiso; A Floreani; R Naccarato; F Rossi; C Del Vecchio Blanco; C Loguercio
Journal:  World J Gastroenterol       Date:  2007-07-21       Impact factor: 5.742

Review 9.  Regulation of vascular tone homeostasis by NO and H2S: Implications in hypertension.

Authors:  Sevda Gheibi; Sajad Jeddi; Khosrow Kashfi; Asghar Ghasemi
Journal:  Biochem Pharmacol       Date:  2018-01-09       Impact factor: 5.858

10.  Effects of Exenatide on Coagulation and Platelet Aggregation in Patients with Type 2 Diabetes.

Authors:  Yaqin Zhang; Ruofei Chen; Yangyang Jia; Mingwei Chen; Zongwen Shuai
Journal:  Drug Des Devel Ther       Date:  2021-07-12       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.